A photo of Chet Villa.

Pediatric Cardiologist, Heart Failure & Transplantation

Associate Professor, UC Department of Pediatrics

513-636-4432

513-636-3952

Board Certified

"I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy..."

About Me

Biography

Children with severe heart disease once had few clinical options. While we’ve made many advances, it’s still critical that we improve therapeutic options and develop new approaches.

At Cincinnati Children’s, I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy, RASopathies, and those in need of ventricular assist device therapy and heart transplant.

My research is focused on finding ways to provide care to children and young adults with heart disease who have limited access to advanced therapies.

Clinical Interests

Advanced heart failure; heart transplantation; cardiomyopathy; mechanical circulatory support

Research Interests

Ventricular assist device therapy; Duchenne muscular dystrophy

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Cardiomyopathy, Rasopathy, Cardio-Oncology, Neuromuscular Cardiology, Neuromuscular Disorders



Blog Posts

Top 5 Things to Know About the Heart in Duchenne Muscular Dystrophy

BlogHeart Conditions

Top 5 Things to Know About the Heart in Duchenne Muscular Dystrophy

By Chet Villa, MD5/30/2019

My Locations

My Education

MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2007.

Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Certification: American Board of Pediatrics, 2010; Pediatric Cardiology, 2014.

My Publications

ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association. Lorts, A; Conway, J; Schweiger, M; Adachi, I; Amdani, S; Auerbach, SR; Barr, C; Bleiweis, MS; Blume, ED; Burstein, DS; et al. Journal of Heart Transplantation. 2021.

Systemic ventricular assist device support in Fontan patients: A report by ACTION. Cedars, A; Kutty, S; Danford, D; Schumacher, K; Auerbach, SR; Bearl, D; Chen, S; Conway, J; Dykes, JC; Jaworski, N; et al. Journal of Heart Transplantation. 2021; 40:368-376.

Commentary: Rejuvenation of a trusted tool. Villa, CR; Morales, DL S. Journal of Thoracic and Cardiovascular Surgery. 2021; 161:1466-1467.

Berlin Heart EXCOR and ACTION post-approval surveillance study report. Zafar, F; Conway, J; Bleiweis, MS; Al-Aklabi, M; Ameduri, R; Barnes, A; Bearl, DW; Buchholz, H; Church, S; Do, NL; et al. Journal of Heart Transplantation. 2021; 40:251-259.

Cardiac medication management in Duchenne muscular dystrophy. Wittekind, SG; Villa, CR. Pediatric Pulmonology. 2021; 56:747-752.

Hemodynamic Response to Device Titration in the Shunted Single Ventricle Circulation: A Patient Cohort Modeling Study. Villa, C; Zafar, F; Lorts, A; Kung, E. ASAIO Journal. 2021.

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Spurney, CF; Ascheim, D; Charnas, L; Cripe, L; Hor, K; King, N; Kinnett, K; McNally, EM; Sauer, JM; Sweeney, L; et al. Open Heart. 2021; 8.

Response by Mital et al to Letter Regarding Article, "A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy ". Mital, S; Armstrong, KR; Butts, RJ; Conway, J; Fan, S; Gardin, L; Kantor, PF; Kaufman, B; Lafreniere-Roula, M; Miron, A; et al. Circulation. 2021; 143:e788-e789.

A novel method of donor‒recipient size matching in pediatric heart transplantation: A total cardiac volume‒predictive model. Szugye, NA; Zafar, F; Ollberding, NJ; Villa, C; Lorts, A; Taylor, MD; Morales, DL S; Moore, RA. Journal of Heart Transplantation. 2021; 40:158-165.

Impact of mechanical circulatory support on pediatric heart transplant candidates with elevated pulmonary vascular resistance. Thangappan, K; Morales, DL S; Vu, Q; Lehenbauer, D; Villa, C; Wittekind, S; Hirsch, R; Lorts, A; Zafar, F. Artificial Organs. 2021; 45:29-37.